ArriVent BioPharma Inc. C...

18.50
-0.07 (-0.38%)
At close: Mar 28, 2025, 1:58 PM

ArriVent BioPharma Common Stock Ratios Statement

Year FY24 FY23 FY22 FY21
PE Ratio -10.42 -9.22 -18.15 -12.98
PEG Ratio -0.58 -0.09 0.64 n/a
PS Ratio n/a n/a n/a n/a
PB Ratio 3.25 4.22 3.84 16.25
P/FCF Ratio -11.94 -11.45 -15.35 -53.22
P/OCF Ratio -11.94 -11.45 -15.35 -53.22
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.00 0.00 n/a
Quick Ratio 13.14 13.78 21.84 23.63
Current Ratio 13.14 13.76 21.84 23.63
Asset Turnover n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a
Return on Equity (ROE) -0.31 -0.46 -0.21 -1.25
Return on Assets (ROA) -0.29 -0.43 -0.2 -1.2
Return on Capital (ROIC) n/a -0.49 -0.21 -0.21
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a